IRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its preliminary, ...
Beta Bionics Inc. (BBNX) reported its Q1 2025 earnings on May 6, revealing a wider-than-expected loss. The company posted an earnings per share (EPS) of -$0.93, missing the forecast of -$0.42. Despite ...
Beta Bionics Inc. reported its second-quarter earnings for 2025, showing a notable improvement in financial performance. The company posted an earnings per share (EPS) of -$0.39, beating the forecast ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback